1-deoxynojirimycin has been researched along with inositol in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (24.32) | 18.7374 |
| 1990's | 7 (18.92) | 18.2507 |
| 2000's | 4 (10.81) | 29.6817 |
| 2010's | 15 (40.54) | 24.3611 |
| 2020's | 2 (5.41) | 2.80 |
| Authors | Studies |
|---|---|
| Chida, N; Furuno, Y; Ikemoto, H; Ogawa, S | 1 |
| Holland, PC; Trudel, GC | 3 |
| Falchetto, R; Keller, P; Legler, G; Semenza, G; Wacker, H | 1 |
| Beuth, J; Ko, HL; Ohshima, Y; Pulverer, G; Roszkowski, K; Uhlenbruck, G; Yassin, A | 1 |
| Bourbouze, R; Donsimoni, R; Lalegerie, P; Legler, G | 1 |
| Herscovics, A; Holland, PC; Trudel, GC | 1 |
| Bause, E; Fuhrmann, U; Ploegh, H | 1 |
| Fiehn, NE; Moe, D | 1 |
| Elbein, AD | 1 |
| Bosch, JV; Schwarz, RT | 1 |
| Bosch, FX; Legler, G; Orlich, M; Rott, R; Schwarz, RT | 1 |
| Elbein, AD; Kyossev, ZN; Kyosseva, SV | 1 |
| Candurra, NA; Damonte, EB; Silber, AM | 1 |
| Mooradian, AD; Thurman, JE | 1 |
| Saito, T; Yamaguchi, I | 1 |
| Scheen, AJ | 1 |
| Akkermans, RP; Lucassen, PL; Rutten, GE; Van de Laar, FA; Van de Lisdonk, EH; Van Weel, C | 1 |
| Kasuga, M; Sakaguchi, K | 1 |
| Daida, H; Fukao, K; Fukushima, Y; Hiki, M; Hirose, K; Kiyanagi, T; Kume, A; Kurata, T; Matsumori, R; Miida, T; Miyazaki, T; Ohmura, H; Ohsaka, H; Shimada, K; Sumiyoshi, K | 1 |
| An, N; Dai, XM; Li, HY; Wu, JM; Zhang, QM | 1 |
| Fujita, H; Hosoba, M; Morii, T; Narita, T; Sato, T; Tsukiyama, K; Yamada, Y; Yamashita, R; Yokoyama, H | 1 |
| Schnell, O; Standl, E | 1 |
| Fujii, M; Ichikawa, M; Imagawa, M; Inaba, S; Kimura, T; Konoshita, T; Miyamori, I; Sato, S; Suzuki, J; Takahashi, S; Zenimaru, Y | 1 |
| Platt, FM; Rahim, AA; Ridley, CM; Shanahan, J; Shen, A; Thillaiappan, NB; Thur, KE; Uhl, K; van der Spoel, AC; Waddington, SN; Walden, CM | 1 |
| Hanaoka, H; Hashimoto, N; Ishikawa, K; Kanatsuka, A; Kobayashi, K; Kuribayashi, N; Onishi, S; Sakurai, K; Sato, Y; Takemoto, M; Terano, T; Uchida, D; Yokoh, H; Yokote, K | 1 |
| Aguilar-Moncayo, M; Garcia Fernandez, JM; Higaki, K; Mena-Barragán, T; Nanba, E; Ohto, U; Ortiz Mellet, C; Shimizu, T; Suzuki, H; Suzuki, Y | 1 |
| Fuchigami, M; Goda, T; Hariya, N; Inoue, S; Mochizuki, K; Osonoi, T; Saito, M | 1 |
| Alvarez-Fischer, D; Andreas, H; Hirsch, EC; Höglinger, GU; Höllerhage, M; Lu, L; Noelker, C; Oertel, WH; Roscher, R; Sturn, A; Vulinovic, F | 1 |
| Fukase, H; Harigai, M; Iida, S; Ikeda, S; Kasahara, N; Miyata, K; Ohba, Y; Saito, T; Takano, Y; Terao, K | 1 |
| Babu, RJ; Dash, RP; Srinivas, NR | 1 |
| Jedrzejczak, RP; Joachimiak, A; Tan, K; Tesar, C; Wilton, R | 1 |
| Davis, SN; Hedrington, MS | 1 |
| Alssema, M; Blaak, EE; Dekker, JM; Denise Robertson, M; Dussort, P; Egli, L; Ruijgrok, C; Vinoy, S | 1 |
| Kaur, N; Kaur, P; Kumar, V; Nayak, SK; Sahu, SK; Wadhwa, P | 1 |
10 review(s) available for 1-deoxynojirimycin and inositol
| Article | Year |
|---|---|
Inhibitors of oligosaccharide processing.
Topics: 1-Deoxynojirimycin; Alkaloids; Animals; Biological Transport; Carbohydrate Conformation; Cyclohexenes; Glucosamine; Glucosidases; Glucosyltransferases; Indolizines; Inositol; Intracellular Fluid; Mannosidases; Models, Chemical; Oligosaccharides; Polysaccharides; Swainsonine | 1985 |
Inhibitors of the biosynthesis and processing of N-linked oligosaccharides.
Topics: 1-Deoxynojirimycin; Acetylglucosamine; Alkaloids; Animals; Anti-Bacterial Agents; Asparagine; Bacitracin; Biological Transport; Carbohydrate Conformation; Cyclohexenes; Dolichol Phosphates; Glucosamine; Glucose; Glycoproteins; Hydroxycholesterols; Indolizines; Inositol; Lipopeptides; Lovastatin; Mannose; Naphthalenes; Oligopeptides; Oligosaccharides; Peptides; Peptides, Cyclic; Phospholipids; Polyisoprenyl Phosphate Monosaccharides; Pyrimidine Nucleosides; Showdomycin; Structure-Activity Relationship; Swainsonine; Tunicamycin; Uracil | 1984 |
Drug therapy of postprandial hyperglycaemia.
Topics: 1-Deoxynojirimycin; Acarbose; Amyloid; Carbamates; Diabetes Mellitus; Enzyme Inhibitors; Glucosamine; Glyburide; Humans; Hyperglycemia; Hypoglycemic Agents; Imino Pyranoses; Inositol; Insulin; Insulin Lispro; Islet Amyloid Polypeptide; Piperidines; Postprandial Period; Trisaccharides | 1999 |
Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus?
Topics: 1-Deoxynojirimycin; Acarbose; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Inositol; Randomized Controlled Trials as Topic | 2003 |
Alpha-glucosidase inhibitors for type 2 diabetes mellitus.
Topics: 1-Deoxynojirimycin; Acarbose; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Inositol; Randomized Controlled Trials as Topic | 2005 |
[Adverse effects of alpha-glucosidase inhibitors].
Topics: 1-Deoxynojirimycin; Acarbose; Digestive System Diseases; Drug Interactions; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hyperammonemia; Hypoglycemia; Hypoglycemic Agents; Imino Pyranoses; Inositol | 2007 |
Alpha-glucosidase inhibitors 2012 - cardiovascular considerations and trial evaluation.
Topics: 1-Deoxynojirimycin; Acarbose; Cardiovascular Diseases; Diabetes Complications; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Inositol | 2012 |
Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes.
Topics: 1-Deoxynojirimycin; Acarbose; Aged; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Inositol; Metformin; Prediabetic State | 2019 |
Effects of alpha-glucosidase-inhibiting drugs on acute postprandial glucose and insulin responses: a systematic review and meta-analysis.
Topics: 1-Deoxynojirimycin; Acarbose; Diabetes Mellitus; Glucose; Glycoside Hydrolase Inhibitors; Humans; Inositol; Insulin; Postprandial Period | 2021 |
Alpha-amylase as molecular target for treatment of diabetes mellitus: A comprehensive review.
Topics: 1-Deoxynojirimycin; Acarbose; alpha-Amylases; Benzofurans; Blood Glucose; Diabetes Mellitus; Drug Discovery; Flavonoids; Glycoside Hydrolase Inhibitors; Humans; Hydrazones; Hypoglycemic Agents; Indoles; Inositol; Oxadiazoles; Structure-Activity Relationship | 2021 |
6 trial(s) available for 1-deoxynojirimycin and inositol
| Article | Year |
|---|---|
Single administration of alpha-glucosidase inhibitors on endothelial function and incretin secretion in diabetic patients with coronary artery disease - Juntendo University trial: effects of miglitol on endothelial vascular reactivity in type 2 diabetic p
Topics: 1-Deoxynojirimycin; Aged; Coronary Artery Disease; Coronary Disease; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelium, Vascular; Enzyme Inhibitors; Female; Glucose; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Incretins; Inositol; Lipid Metabolism; Male; Middle Aged; Treatment Outcome | 2010 |
Comparisons of the effects of 12-week administration of miglitol and voglibose on the responses of plasma incretins after a mixed meal in Japanese type 2 diabetic patients.
Topics: 1-Deoxynojirimycin; Asian People; Diabetes Mellitus, Type 2; Drug Administration Schedule; Female; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Incretins; Inositol; Male; Middle Aged; Obesity; Postprandial Period | 2012 |
Differential effects of α-glucosidase inhibitors on postprandial plasma glucose and lipid profile in patients with type 2 diabetes under control with insulin lispro mix 50/50.
Topics: 1-Deoxynojirimycin; Apolipoprotein A-I; Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Inositol; Insulin Lispro; Lipids; Lipoproteins, HDL; Male; Middle Aged; Postprandial Period; Treatment Outcome; Triglycerides | 2012 |
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with α-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on sulfonylurea alone (SUCCESS-2): a multicenter, randomized, open-label, non-i
Topics: 1-Deoxynojirimycin; Aged; alpha-Glucosidases; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Gastrointestinal Agents; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Inositol; Japan; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Sulfonylurea Compounds; Triazoles | 2014 |
Switching α-glucosidase inhibitors to miglitol reduced glucose fluctuations and circulating cardiovascular disease risk factors in type 2 diabetic Japanese patients.
Topics: 1-Deoxynojirimycin; Acarbose; Aged; Asian People; Blood Glucose; Cardiovascular Diseases; Chemokine CCL2; Diabetes Mellitus, Type 2; Drug Therapy, Combination; E-Selectin; Female; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Inositol; Insulin; Male; Middle Aged; Prospective Studies; Risk Factors; Time Factors | 2014 |
A Pharmacokinetic/Pharmacodynamic Drug-Drug Interaction Study of Tofogliflozin (a New SGLT2 Inhibitor) and Selected Anti-Type 2 Diabetes Mellitus Drugs.
Topics: 1-Deoxynojirimycin; Adult; Benzhydryl Compounds; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Interactions; Glucose; Glucosides; Healthy Volunteers; Humans; Hypoglycemic Agents; Inositol; Male; Metformin; Middle Aged; Nateglinide; Phenylalanine; Pioglitazone; Sitagliptin Phosphate; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Thiazolidinediones; Urine; Young Adult | 2016 |
21 other study(ies) available for 1-deoxynojirimycin and inositol
| Article | Year |
|---|---|
Synthesis of (+)- and (-)-nojirimycin and their 1-deoxy derivatives from myo-inositol.
Topics: 1-Deoxynojirimycin; Anti-Bacterial Agents; beta-Galactosidase; beta-Glucosidase; Glucosamine; Glycoside Hydrolases; Inositol; Stereoisomerism; Sucrase | 1992 |
Inhibitors of glycoprotein processing act at an early stage of myogenesis.
Topics: 1-Deoxynojirimycin; Actins; Animals; Blotting, Northern; Blotting, Western; Cell Line; Cyclohexenes; DNA Probes; Glucosamine; Glycoproteins; Glycoside Hydrolases; Inositol; Mice; Muscle Proteins; Muscles; MyoD Protein; Myogenin; Rats; RNA | 1992 |
Location of the two catalytic sites in intestinal lactase-phlorizin hydrolase. Comparison with sucrase-isomaltase and with other glycosidases, the membrane anchor of lactase-phlorizin hydrolase.
Topics: 1-Deoxynojirimycin; Amino Acid Sequence; Animals; beta-Galactosidase; Binding Sites; Catalysis; DNA; Glucosamine; Glycoside Hydrolases; Inositol; Intestines; Lactase; Lactase-Phlorizin Hydrolase; Microvilli; Molecular Sequence Data; Oligo-1,6-Glucosidase; Rabbits; Sequence Homology, Nucleic Acid; Sucrase | 1992 |
The glycoprotein-processing inhibitors bromoconduritol and N-methyl-1-deoxynojirimycin alter the adhesion phenotype of skeletal myoblasts.
Topics: 1-Deoxynojirimycin; Amino Acid Sequence; Animals; Cell Adhesion; Cell Differentiation; Cell Fusion; Chick Embryo; Collagen; Cyclohexenes; Extracellular Matrix; Fibronectins; Glucosamine; Glycosylation; Inositol; Integrins; Laminin; Molecular Sequence Data; Muscles; Phenotype; Protein Processing, Post-Translational; Rats; Stem Cells | 1990 |
Effect of inhibitors of glycoprotein processing on integrin and the adhesion of myoblasts to extracellular matrix proteins.
Topics: 1-Deoxynojirimycin; Animals; Cell Adhesion; Cells, Cultured; Chick Embryo; Cyclohexenes; Extracellular Matrix; Fibronectins; Glucosamine; Glycoproteins; Glycoside Hydrolases; Inositol; Integrins; Kinetics; Laminin; Membrane Glycoproteins; Muscles; Protein Processing, Post-Translational; Rats | 1989 |
Glycoprotein modifications of sarcoma L-1 tumor cells by tunicamycin, swainsonine, bromoconduritol or 1-desoxynojirimycin treatment inhibits their metastatic lung colonization in Balb/c-mice.
Topics: 1-Deoxynojirimycin; Alkaloids; Animals; Carbohydrates; Cyclohexenes; Glucosamine; Glycoproteins; Inositol; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Sarcoma, Experimental; Swainsonine; Tunicamycin | 1988 |
Study of beta-glucosidase from Helix pomatia by active site-directed inhibitors.
Topics: 1-Deoxynojirimycin; Animals; beta-Glucosidase; Glucosamine; Glucosidases; Helix, Snails; Hydrogen-Ion Concentration; Inositol; Kinetics; Substrate Specificity | 1988 |
Inhibition of myoblast fusion by bromoconduritol.
Topics: 1-Deoxynojirimycin; Animals; Anti-Bacterial Agents; Catalysis; Cell Fusion; Cell Line; Cyclohexenes; Glucosamine; Glucosidases; Inositol; Lactoperoxidase; Membrane Proteins; Molecular Weight; Muscles; Rats | 1988 |
Effect of seven inhibitors on invertases in homogenates of human dental plaque.
Topics: 1-Deoxynojirimycin; Acarbose; beta-Fructofuranosidase; Dental Plaque; Glucosamine; Glucosidases; Glycoside Hydrolase Inhibitors; Glycoside Hydrolases; Humans; Inositol; Peptides; Piperidones; Trisaccharides | 1983 |
Processing of gPr92env, the precursor to the glycoproteins of Rous sarcoma virus: use of inhibitors of oligosaccharide trimming and glycoprotein transport.
Topics: 1-Deoxynojirimycin; Avian Sarcoma Viruses; Biological Transport, Active; Cells, Cultured; Cyclohexenes; Glucosamine; Glycoproteins; Inositol; Kinetics; Oligosaccharides; Viral Proteins; Virion | 1984 |
Effect of inhibitors of glycosylation on proteolytic activation of avian influenza virus hemagglutinins: discrimination between tryptic cleavage and elimination of the connecting peptide.
Topics: 1-Deoxynojirimycin; Carbohydrate Metabolism; Cyclohexenes; Deoxyglucose; Glucosamine; Hemagglutinins, Viral; Influenza A virus; Inositol; Trypsin; Tunicamycin; Virion | 1984 |
Inhibitors of pig kidney trehalase.
Topics: 1-Deoxynojirimycin; Animals; Carbohydrate Sequence; Disaccharides; Glucosidases; Indolizines; Inositol; Intestine, Small; Kidney Cortex; Molecular Sequence Data; Rats; Sucrase; Sugar Alcohols; Swine; Trehalase; Yeasts | 1995 |
The effects of oligosaccharide trimming inhibitors on glycoprotein expression and infectivity of Junin virus.
Topics: 1-Deoxynojirimycin; alpha-Glucosidases; Animals; Arenaviruses, New World; Cyclohexenes; Fluorescent Antibody Technique; Glycoproteins; Glycoside Hydrolase Inhibitors; Inositol; Oligosaccharides; Swainsonine; Vero Cells; Viral Proteins; Virus Replication | 1993 |
Effect of glycosylation and glucose trimming inhibitors on the influenza A virus glycoproteins.
Topics: 1-Deoxynojirimycin; Animals; Antibodies, Monoclonal; Antiviral Agents; Cell Line; Colony Count, Microbial; Cyclohexenes; Enzyme Inhibitors; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Glucosidases; Glycosylation; Hemagglutinin Glycoproteins, Influenza Virus; Indolizines; Influenza A virus; Inositol; Neuraminidase; Reassortant Viruses; Tunicamycin | 2000 |
Development and validation of HPLC-UV-MS method for the control of four anti-diabetic drugs in suspected counterfeit products.
Topics: 1-Deoxynojirimycin; Acarbose; alpha-Glucosidases; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Inositol; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet | 2010 |
Intestinal alpha-glucosidase inhibitors: abdominal gas cysts.
Topics: 1-Deoxynojirimycin; Acarbose; Aged; Aged, 80 and over; alpha-Glucosidases; Enzyme Inhibitors; Female; Gases; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Inositol; Intestinal Mucosa; Male; Middle Aged; Pneumatosis Cystoides Intestinalis; Predictive Value of Tests; Risk Assessment; Risk Factors | 2012 |
β-Glucosidase 2 (GBA2) activity and imino sugar pharmacology.
Topics: 1-Deoxynojirimycin; Animals; beta-Glucosidase; Cell Line, Tumor; Cerebellar Ataxia; Chlorocebus aethiops; COS Cells; Enzyme Inhibitors; Glucosylceramidase; Humans; Hydrogen-Ion Concentration; Inositol; Mice; Spastic Paraplegia, Hereditary | 2013 |
Structural basis of pharmacological chaperoning for human β-galactosidase.
Topics: 1-Deoxynojirimycin; beta-Galactosidase; Catalytic Domain; Crystallography, X-Ray; Cyclohexenes; Enzyme Inhibitors; Enzyme Stability; Gangliosidosis, GM1; Hexosamines; Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Imino Sugars; Inositol; Kinetics; Models, Molecular; Molecular Structure; Mucopolysaccharidosis IV; Mutation; Protein Structure, Tertiary; Static Electricity; Structure-Activity Relationship | 2014 |
Glucocerebrosidase deficiency and mitochondrial impairment in experimental Parkinson disease.
Topics: 1-Deoxynojirimycin; 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Cell Count; Cells, Cultured; Disease Models, Animal; Embryo, Mammalian; Gaucher Disease; Glycoside Hydrolase Inhibitors; Histocompatibility Antigens; Inositol; L-Lactate Dehydrogenase; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Mitochondrial Diseases; Neurons; Parkinsonian Disorders; Tyrosine 3-Monooxygenase | 2015 |
Reappraisal and perspectives of clinical drug-drug interaction potential of α-glucosidase inhibitors such as acarbose, voglibose and miglitol in the treatment of type 2 diabetes mellitus.
Topics: 1-Deoxynojirimycin; Acarbose; Diabetes Mellitus, Type 2; Drug Interactions; Humans; Hypoglycemic Agents; Inositol | 2018 |
Interaction of antidiabetic α-glucosidase inhibitors and gut bacteria α-glucosidase.
Topics: 1-Deoxynojirimycin; alpha-Glucosidases; Bacterial Proteins; Gastrointestinal Microbiome; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Inositol; Models, Molecular; Protein Binding; Ruminococcus | 2018 |